A 2 × 2 factorial design for the combination therapy of minocycline and remote ischemic perconditioning: Efficacy in a preclinical trial in murine thromboembolic stroke model

Experimental and Translational Stroke Medicine

Volumn 6, Issue 1, 2014, Pages

  Hoda, Md Nasrul ^a,b,c,d   Fagan, Susan C ^a,c,d   Khan, Mohammad B ^a,d   Vaibhav, Kumar ^b   Chaudhary, Aizaz ^a,b   Wang, Phillip ^a   Dhandapani, Krishnan M ^a   Waller, Jennifer L ^b   Hess, David C ^a,c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b AUGUSTA UNIVERSITY   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d Charlie Norwood VA   (United States)

Author keywords

Intravenous tPA; Minocycline; Neurovascular protection; Remote ischemic perconditioning; Thromboembolic stroke

Indexed keywords

MINOCYCLINE; TISSUE PLASMINOGEN ACTIVATOR;

ADHESIVE REMOVAL TEST; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; HEART INFARCTION PREVENTION; LASER SPECKLE CONTRAST IMAGING; MALE; MIDDLE AGED; MOUSE; NEUROIMAGING; NEUROLOGICAL DEFICIT SCORE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REMOTE ISCHEMIC PRECONDITIONING; SCORING SYSTEM;

EID: 84989298274     PISSN: None     EISSN: 20407378     Source Type: Journal    
DOI: 10.1186/2040-7378-6-10     Document Type: Article

References (23)

1. Albers GW, Goldstein LB, Hess DC, Wechsler LR, Furie KL, Gorelick PB, Hurn P, Liebeskind DS, Nogueira RG, Saver JL, STAIR VII Consortium: Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke 2011, 42(9):2645-2650.
2. Audebert HJ, Saver JL, Starkman S, Lees KR, Endres M: Prehospital stroke care: new prospects for treatment and clinical research. Neurology 2013, 81(5):501-508.
3. Saver JL, Starkman S, Eckstein M, Stratton S, Pratt F, Hamilton S, Conwit R, Liebeskind DS, Sung G, Sanossian N, FAST-MAG Investigators and Coordinators: Methodology of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) phase 3 trial: part 2-prehospital study methods. Int J Stroke 2014, 9(2):220-225.
4. Hess DC, Fagan SC: Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline. Pharmacotherapy 2010, 30(7 Pt 2):55S-61S.
5. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M: Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010, 375(9716):727-734.
6. Hougaard KD, Hjort N, Zeidler D, Sorensen L, Norgaard A, Hansen TM, von Weitzel-Mudersbach P, Simonsen CZ, Damgaard D, Gottrup H, Svendsen K, Rasmussen PV, Ribe LR, Mikkelsen IK, Nagenthiraja K, Cho TH, Redington AN, Botker HE, Ostergaard L, Mouridsen K, Andersen G: Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke 2014, 45(1):159-167.
7. Geng X, Ren C, Wang T, Fu P, Luo Y, Liu X, Yan F, Ling F, Jia J, Du H, Ji X, Ding Y: Effect of remote ischemic postconditioning on an intracerebral hemorrhage stroke model in rats. Neurol Res 2012, 34(2):143-148.
8. Koch S, Katsnelson M, Dong C, Perez-Pinzon M: Remote ischemic limb preconditioning after subarachnoid hemorrhage: a phase Ib study of safety and feasibility. Stroke 2011, 42(5):1387-1391.
9. Gonzalez NR, Connolly M, Dusick JR, Bhakta H, Vespa P: Phase I clinical trial for the feasibility and safety of remote ischemic conditioning for aneurysmal subarachnoid hemorrhage. Neurosurgery 2014. Epub ahead of print (PMID: 25072112).
10. Mayor F, Bilgin-Freiert A, Connolly M, Katsnelson M, Dusick JR, Vespa P, Koch S, Gonzalez NR: Effects of remote ischemic preconditioning on the coagulation profile of patients with aneurysmal subarachnoid hemorrhage: a case-control study. Neurosurgery 2013, 73(5):808-815. discussion 815.
11. Murata Y, Rosell A, Scannevin RH, Rhodes KJ, Wang X, Lo EH: Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke 2008, 39(12):3372-3377.
12. Hoda MN, Siddiqui S, Herberg S, Periyasamy-Thandavan S, Bhatia K, Hafez SS, Johnson MH, Hill WD, Ergul A, Fagan SC, Hess DC: Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke. Stroke 2012, 43(10):2794-2799.
13. Hoda MN, Bhatia K, Hafez SS, Johnson MH, Siddiqui S, Ergul A, Zaidi SK, Fagan SC, Hess DC: Remote ischemic perconditioning is effective after embolic stroke in ovariectomized female mice. Transl Stroke Res 2014, 5(4):484-490.
14. Fisher M, Hanley DF, Howard G, Jauch EC, Warach S, STAIR Group: Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes. Stroke 2007, 38(2):245-248.
15. Hoda MN, Li W, Ahmad A, Ogbi S, Zemskova MA, Johnson MH, Ergul A, Hill WD, Hess DC, Sazonova IY: Sex-independent neuroprotection with minocycline after experimental thromboembolic stroke. Exp Transl Stroke Med 2011, 3(1):16.
16. Montgomery AA, Peters TJ, Little P: Design, analysis and presentation of factorial randomised controlled trials. BMC Med Res Methodol 2003, 3:26.
17. McClure LA, Coffey CS, Howard G: Monitoring futility in a two-by-two factorial design: the SPS3 experience. Clin Trials 2013, 10(2):250-256.
18. Hess DC, Hoda MN, Bhatia K: Remote limb perconditioning [corrected] and postconditioning: will it translate into a promising treatment for acute stroke? Stroke 2013, 44(4):1191-1197.
19. Machado LS, Kozak A, Ergul A, Hess DC, Borlongan CV, Fagan SC: Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci 2006, 7:56.
20. Alano CC, Kauppinen TM, Valls AV, Swanson RA: Minocycline inhibits poly (ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci U S A 2006, 103(25):9685-9690.
21. Schildknecht S, Pape R, Muller N, Robotta M, Marquardt A, Burkle A, Drescher M, Leist M: Neuroprotection by minocycline caused by direct and specific scavenging of peroxynitrite. J Biol Chem2011, 286(7):4991-5002.
22. Yenari MA, Xu L, Tang XN, Qiao Y, Giffard RG: Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 2006, 37(4):1087-1093.
23. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J: A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 1999, 96(23):13496-13500.